Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypill strategy for secondary cardiovascular prevention in elderly post-myocardial infarction patients
2015-002868-17Phase 3Completed
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Feb 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of aspirin, ramipril and atorvastatin in myocardial infarction (MI) and cardiac morbidity (2 arms), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Primary endpoint: Primary composite efficacy endpoint. Started Feb 2016; status: completed.
02
Drugs
aspirinramiprilatorvastatin
03
Conditions
myocardial infarction (MI)cardiac morbidity
Beyond the preview
Go deeper on 2015-002868-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002868-17.